Adapting existing sales-force models to fit the specific demands of
biologicsOrrin Hatch (R-UT) and Mike Enzi (R-WY) that would grant 12 years of exclusivity to brand-name
biologics.
"We are very pleased with the progress that Bone
Biologics has made in achieving each of their development milestones over the past four years and look forward to their continued progress toward FDA approval and commercialization on the timelines projected by the company," Bruce Stroever, CEO of MTF said.
Injectable
biologics include four medications, yet account for more than 19% of total specialty-drug per-member per-year expenses.
Kathryn Zoon is Director of the Center for
Biologics Evaluation and Research (CBER) at the Food and Drug Administration.
Samsung
BioLogics, a subsidiary of Samsung C&T Corporation, has signed a Contract Development Organization (CDO) contract with Korea-based drug development company, GI Innovation.
Gustavo joined AGC
Biologics (previously CMC
Biologics) in 2008 as president.
WuXi
Biologics and Amicus Therapeutics announced that the companies have entered into an exclusive commercial manufacturing partnership for Amicus' Pompe
biologic ATB200.
WuXi
Biologics (2269.HK), a leading global open-access
biologics technology platform company offering end-to-end solutions for
biologics discovery, development and manufacturing, and Immune Pharmaceuticals (Nasdaq: IMNP) ('Immune'), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, today announced a development and manufacturing agreement for the production of bertilimumab, Immune's first-in-class anti-eotaxin-1 monoclonal antibody, Monday (7/9).
As of last year, the NPS held a 2.8 percent stake or 1.97 million ordinary shares in Samsung
BioLogics. Samsung
BioLogics spokesman Seo Hae-su said the company has no official comments on this issue.
Pune, India, June 16, 2016 --(PR.com)-- Global Subcutaneous
Biologics market research report is the latest business intelligence offering overview on Subcutaneous
Biologics including competitive landscape, classifications, applications and industry chain structure.